HBIO President, David Green, to Present At US Bancorp Piper Jaffray Healthcare Conference
Harvard Bioscience, Inc. President, David Green to Participate at Thomas Weisel Partners Healthcare Tailwinds Conference 2002
HBIO President, David Green, to Present At US Bancorp Piper Jaffray Healthcare Conference
Harvard Bioscience Believes the Affymetrix and OGT Disputes Over Pre-Printed Microarrays Will Have No Impact on Forecasted Revenues or Earnings as this Product Line was Eliminated, as Planned, in 2002.
Harvard Bioscience President David Green to Present at Thomas Weisel Partners Healthcare Conference in Boston on September 3rd 2003
Harvard Bioscience Presentation at Informed Investors Biotechnology/Healthcare Stocks Forum to be Webcast On Thursday, November 13, 2003, 9 am ET
HBIO President David Green to Present at Rodman and Renshaw Techvest Global Healthcare Conference in London, England on May 12th 2004
HBIO President Adopts 10b5-1 Plan
HBIO Announces June 2nd 2005 Investor Presentation of its Strategic Growth Plans and Changes to the Presentation of its Future Financial Results
HBIO Announces Plan to Divest its Capital Equipment Business And Delays Reporting its Q2 Results Pending Resolution of Whether the Company met the Criteria for ''Held for Sale'' Accounting for the Capital Equipment Business
